ATI RN
ATI Pharmacology 2023 Questions
Extract:
Question 1 of 5
A nurse is assessing a client who has started taking theophylline. Which of the following client findings should indicate to the nurse that the medication is effective?
Correct Answer: B
Rationale: Theophylline is used to manage asthma and COPD; decreased wheezing indicates improved airflow and effectiveness.
Question 2 of 5
A nurse is preparing to administer a scheduled dose of warfarin to a client. Which of the following laboratory tests should the nurse review prior to administration?
Correct Answer: A
Rationale: PT measures the time it takes for blood to clot, and it is particularly relevant for clients taking warfarin because warfarin works by inhibiting the synthesis of certain clotting factors, including factors II, VII, IX, and X, which are involved in the PT pathway. Monitoring PT levels helps ensure that the client is receiving an appropriate dose of warfarin to prevent clot formation without causing excessive bleeding.
Question 3 of 5
A nurse is assessing a client who has started taking theophylline. Which of the following client findings should indicate to the nurse that the medication is effective?
Correct Answer: B
Rationale: Theophylline is used to manage asthma and COPD; decreased wheezing indicates improved airflow and effectiveness.
Question 4 of 5
A nurse is caring for a client who is receiving magnesium sulfate IV bolus for preeclampsia. The client's respiratory rate is 6/min and they have absent deep tendon reflexes. Which of the following medications should the nurse anticipate the provider to prescribe?
Correct Answer: B
Rationale: Calcium gluconate is the antidote for magnesium sulfate toxicity, indicated by respiratory depression and absent reflexes.
Question 5 of 5
A nurse in a provider's office is evaluating the effectiveness of alendronate for a client who has osteoporosis. Which of the following diagnostic results should the nurse review?
Correct Answer: C
Rationale: A DEXA scan measures bone density, indicating the effectiveness of alendronate in treating osteoporosis.